Cough-Cold and Flu

TARRYTOWN, N.Y. — Cough-cold suppliers are presently operating in a challenging environment, noted Matthew Mannelly, Prestige Brands CEO, president and director, during a conference call Thursday. The return of Tylenol to the cough-cold aisle and the accompanying media splash from McNeil Consumer isn't the only competitive factor impacting the cough-cold category, Mannelly said. The season is down more than 15% versus last year. And that lack of consumption, coupled with an overall soft retail environment, is forcing retailers to significantly cut back on inventories. 

CHARLESTON, W.Va. — West Virginia took one step closer to making pseudoephedrine products prescription-only, as the state's Senate Committee on Health voted Tuesday to move ahead with the proposal, according to an Associated Press report. 

According to the report, the bill would allow an exception for certain over-the-counter drugs that are deemed "tamper resistant" by the Board of Pharmacy.

NEW YORK — Hy-Vee has teamed up with the University of Nebraska Medical Center College of Pharmacy and Ferris State University to offer rapid-diagnostic flu and strep tests in its pharmacies.

Hy-Vee stores in Omaha and Papillion are among 60 sites throughout three states that will have pharmacists trained to administer these tests, the results of which are available shortly after the test is given. In addition to the testing, pharmacists also will be able to fill prescriptions to treat identified illnesses, if needed, under protocol set by prescribing physicians.

BASEL, Switzerland — Novartis Consumer Health will be relaunching Theraflu for the 2014-2015 cough-cold season, Brian McNamara, Novartis division head OTC, told analysts Wednesday. 

"As you know, in the U.S. business we launched Lamisil and Triaminic and Excedrin end of 2012 and 2013. About halfway through the year, we launched Benefiber. And for next year, we expect to launch Theraflu for that cough and cold season," he said.